Regioselective acetylation at C-2 was accomplished kng acetic anhydride and ZnClz as a catalyst. Vmier a variety of other conditions the 29diacetylproduct wasformed and no 9-monoacetylated compound could be isolated. Just as the parent compound, the acetylated deasaellipticines showed only very low cyrostatic activity.
INTRODUCTION
The alkaloid ellipticine (5,l l-dimethyl-W-pyrido [4,3- In order to functionaliz.e the 1 I-methylgroup an attempt by our group was made to apply well known pyridine-N-oxide chemistry to the pyridocarbazole system since the 1 I-methylgroup is conjugatively analogous to the methylgroup in 2-methylpyridine .*c Upon reacting 6-methylellipticine-N-oxide (2) wltb Ac,O the carbazolone derivatives 3 and 4 were isolated instead of the desired 1 l-functionalixed ellipticines (Scheme 1).
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Scheme 1
Extending this idea of making the oxygen part of a leaving group, other reactants such as p-TosCl or MsCl can replace A%0 for the synthesis of 1-functionalized ellipticines. Our interest was stimulated further by papers which dealt with the reactions of heterocyclic N-oxides with A~20 and p-TosCl. Reaction of quinoline-N-oxide with Ac,O or p-TosCl gave quinolin-2-( W)-one.t4 Iscquinoline-N-oxide reacted in a similar manner with Ac,O but upon treatment with p-To&l 4-tosylisoquinoline was isolated instead. Since the ellipticineskeleton contains an isoquinoline structure, this result could in principle open a way for the synthesis of 4-substituted ellipticines.
The mechanism of the reaction of isoquinoline-N-oxide (5) to 6 with p-TosCl has been extensively investigated using p-TosC1 labelled with t*O and it is assumed that the rearrangement proceeds via an intimate ion pair (8) since almost no scrambling of the isotopes was observed (Scheme 2).tsJ6Afte.r reaction of the tosylgroup with the N-oxide function of 5 to 6 the chloride-ion adds to C-l (7) whereafter the tosyloxygroup shifts to C-4 (9) via 8 retaining its stereochemical structure. Finally hydrochloric acid eliminates from 9 to give 4-tosylisoquinoline (10).
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Scheme 2
Ring D modifications of ellipticine-II 4813 It has been established that there are several ways by which elllpticines can express their antitumour activity.
After the discovery of its antitumour activity intercalation due to its planar structure, was assumed to be responsible for the activity?rJ* Since 9-hydroxyellipticine (11) also showed high antitumour activity, another possibility of antitumour action was proposed. 1920 Oxidation of 11 should lead to the formation of a quinonimine which has been shown to react in vitro with ribonucleos(t)ides and with amino acids to form oxazolopyridocarbazoles 12 (Scheme 3).zta Recent developments show a thiid way in which topoisomerase II is playing a central role.P* Serious doubt was raised by Archer et. al about the quinonimine theory?5% They suggested an alternative in which the S-methylgroup plays a central role. Reinvestigation of the available literature concerning the biological activity of ellipticines led them to the conclusion that the S-methylgroup is essential for antitumour action. They therefore synthesized 9-hydroxy-6Zf-pyrido [4,3-b] carbazole (13) which upon oxidation in the presence of amino acids formed oxazolopyridocarbazoles of type 14 (Scheme 3). Although 13 could be oxidized to a quinonimine, the compound was shown to be devoid of any cytotoxic activity, thus establishing that a 9-hydroxy function is not sufficient for antitumour activity.
11 R,= R,= CH3 13 R,=Rz= H 12 Rt= RZ= CH3 14 R,= RZ= H R3= Amino acid residue
Scheme 3
Research performed in our group showed that the 9-hydroxy function is also not a condition for cytostatic activity.'3 We found that 9-acylated ellipticines showed unexpected high antitumour activity. For instance 9-acetyl-6methylellipticine (15) showed an It& value against B16 melanoma of 44 ng/ml similar to 9-hydmxy-2-methylellipticinium acetate (16, elliptinium@) , the clinically active drug (Figure 2 ).aJr This result is remarkable since conversion into a hydroxy group via an enzymatic Baeyer-Villiger oxidation is unlikely. Up till now the only enzyme mediated Baeyer-Villiger oxidation has been found in a bacteria.28
Therefore the 9-acylellipticines should display their activity via a hitherto unknown mechanism, probably without interference of a quinonimine.
Although the deaza-analogues of ellipticine showed little or no antitumour activity the results mentioned above, stimulated us to synthesize the deaza-analogue of 15. In this paper we wish to report on the synthesis of 
17
RESULTS
SYNTHESIS OF THE CHLORO-ELLIPTICINES
Starting from ellipticine (l), 6methylellipticine (18) and 6benzylellipticine (19) were prepared by deprotonation of 1 in THP or DMP with NaH followed by the addition of CH$ or PhCH2Br. 
Scheme 4
Reactions of p-TosCl with 2 in the presence of nucleophiles like KOH or NaOAc did not give unequivocal results and since the chloride ion is a weak nucleophile we investigated if it interfered with the reaction. Thus a series of acid chlorides was reacted with 2 to give the same product which could be identified as 3-chloro-6 methylellipticine ( 
Scheme 5
The results mentioned above contradict those obtained by Ochiai and Oae for isoquinoline-N-oxide.rsJ6
They isolated I-tosyloxy-or 4-hydroxy-isoquinolines upon reaction of isoquinoline-N-oxide with p-TosCl.
Therefore it was tempting to speculate if this result was influenced by the presence of the methylgroups. To investigate this proposition we synthesized the corresponding substituted isoquinoline-N-oxide (25) (Scheme 6). This compound was obtained via condensation of 2,Sdimethylhenzaldehyde (26) 
Scheme 7
With several 3-chloroellipticines substitution experiments were performed but these resulted only in the formation of tarry substances from which no products could be isolated. This resembles the lack of reactivity observed for 3-chloro-isoquinolines. Here substitution is only accomplished under forcing reaction conditions.32 In order to obtain selective acetylation at C-2 of 17 a mild acetylating agent must be used since on both C-2 and C-9 the electron density is influenced by the nitrogen atom making both susceptible to electmphilic attack.
The only difference between these positions is the length of the mesomeric system. This difference must decide if and where the acetylgroup will be introduced, at C-2 or at C-9.
The acetylgroup can he introduced via a Friedel-Crafts acetylation. The variety of reagents and catalysts aivalable for this reaction offers a good prospect to achieve selective acetylation of 17 although Mabille and Buu-Hdi found that SH-benzo[b]carbazole was acetylated on both C-2 and C-9.39 Also by the presence of the methylgroups high selectivity might be be expected using mild reagents such as AcZO and ZnCl,.~
The acetylation reactions of 17 were performed on a small scale using AcCl and A30 as acetylating agents in combination with several catalysts to find the optimal conditions for selective acetylation (Table 1) . According to TLC analysis both mono-(37) and disubstituted (38) products were formed in the reactions. No mono acetylation product at C-9 (39) could be identified suggesting that this position reacts only after acetylation at 4818 A. T. BOOGAARD et al.
C-2 has occurred. From table 1 it is clear that selective acetylation is possible using ZnClZ and Ac20 in nitrobenzene and diacetylation can be achieved in CHClp Furthermore in most of the reactions both products am formed which is indicative for the minor difference in electron density of C-2 and C-9. The formation of a single product in nitrobenxene can be attributed to the formation of a large complex composed of catalyst, solvent and reagent which experiences steric hindrance from the 1 1-methylgroup when acetylating at C-9.41 Table 1 Reaction conditions for the acetylation of 17 
R= H, CH3, CH2Ph
ri. CH3 ri CH, 41 Scheme 
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In the reaction of 42 with p-TosCl the chloride-ion can add to both C-1 and C-3 since both addition products are isolated (Scheme 11). Here addition to C-1 is preferred since the aromatic@ of the benzene ring is not disturbed. Upon elimination of TosOH from43 the 1-chloro-5,8dimethylisoquinoline (44) which is further unreactive towards the reaction conditions. Thus for 42 addition to C-l is preferred over C-3 despite the more crowded surrounding of C-1.
A remarkable aspect of this reaction is that no shift of the tosylgroup is observed in contrast with the mechanistic studies of Ochiai and Oae .tsJ6 The difference in observations are probably caused by the different solvents used. Ochiai and Oae performed their reactions in CH2Cl2 while DMF is used in this work. DMF has the ability to act as a base by deprotonation of the intermediate adduct immediately after its formation thereby preventing the shift of the tosyloxygroup to C-4.
A. T. BOOGAARD etal.
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ANTITUMOUR ACTIVITY
The compounds 17.23 and 37 were tested for their antitumour activity and they showed a comparable rather low activity against an in vitro cultum of WiDR (It& for 17= 3.0 @ul and IC% for 37= 3.
&$nl).4s
This result suggests that the pyridine nitrogen atom in ellipticine is a condition for useful antitumour activity. The antitumour activity of 23 was tested against an in vitro culture of L1210 cells but it proved to be inactive. 
EXPERIMENTAL
General remarks and materials
Ring D modifications of ellipticine--II 4821
General procedure for synthesb of ellipticine-N-oxides
To a solution of the appropriate ellipticine in CI$Clz (25 ml) at 0 qC was added m-CPBA (1.5 eq). The solution was stirred for 6 h then a saturated aqueous solution of NaHCOs (50 ml) was added and after 0.5 h the organic layer was separated. The waterlayer was extracted with CH$!lz ( 3 x 25 ml) and the combined organic fractions were washed with saturated aqueous solution of NaHCO3 (2 x 50 ml), water (2 x 50 ml), brine (2 x 50 ml) and dried (MgSO4). The residue obtained after filtration was subjected to flash chromatography (silica, eluent: General procedure for synthesis of 3-chloro-ellipticin A solution of the N-oxide in dry DMF (15 ml) is heated to 80 93 under an atmosphere of dry nitrogen. Then p-TosCl(6 eq) is added and the mixture is stirred for 6 h at 80 C. The reaction is stopped by carefully pouring the solution into an aqueous saturated solution of NaHC03 (50 ml) under vigorous stirring. After stirring for 0.5 h the solution is extracted with CHCl, (3 x25 ml). The combined organic fractions are successively washed with water (2 x 100 ml), brine (2 x 100 ml) and dried (MgSO4). After filtration and evaporation of the-solvent the residue was subjected to flash chromatography (silica, eluent; CHC&/EtOH: 100/O, 99/l, 98/2,95/5, v/v). 
S,8-dimethylisoquinoline (2 9)
To concentrated &SO, (50 ml) at 160 C under an armosphem of dry nitrogen was added slowly a solution of 21 (1.13 gr, 5.1 mmoi) in dry MeOH (5 ml). The reaction mixture was stirred at 160 SC for 2 h, cooled to R.T.
and pouted carefully on to crushed ice (250 ml). The resulting mixture cautiously was neutralized with solid NaOH to pH 9. The product was removed from the black solution by steamdestillation. The product was extracted from the distillate with ether (3 x 50 ml) and the combined organic fractions were washed with brine (2 x 50 ml) and dried (MgSO4 to pH -7. After concentrating to about 50 ml concentrated HCl(25 ml) was added. The resulting mixture was heated to reflux during 4 h and after cooling to R.T. extracted with CI-+Clz (3 x 50 ml). The combined organic fractions were washed with water (2 x 50 ml) and dried (MgS04). The residue obtained after evaporation of the solvent was subjected to flash chromatography (silica, eluent: petroleum ether 60-80/EtOAc; 100/O, 90/10,
